Apixaban

Fa'amatalaga Puupuu:

Igoa API Fa'ailoga Fa'amatalaga US DMF EU DMF CEP
Apixaban VTE I totonu o le Fale


Fa'amatalaga Oloa

Faailoga o oloa

FAAMATALAGA O MEA FAI

Talaaga

O le Apixaban o se inhibitor sili ona filifilia ma toe faʻafoʻi o Factor Xa faʻatasi ai ma Ki tau o le 0.08 nM ma le 0.17 nM i le tagata ma le lapiti, i le faasologa [1].

Factor X, e lauiloa foi i le eponym Stuart-Prower factor, o se enzyme o le coagulation cascade.O le Factor X e fa'agaoioia, e ala ile hydrolysis, ile fa'ale Xa e lua itu IX.Factor Xa o le fa'agaoioia fomu o le coagulation factorthrombokinase. Inhibiting Factor Xa e mafai ona ofoina atu se isi auala mo anticoagulation.Direct Xa iniseti o anticoagulants lauiloa [2].

In vitro: Apixabanhas na faʻaalia se maualuga maualuga o le malosi, filifilia, ma le aoga ile Factor Xa ma le Ki o le 0.08 nM ma le 0.17 nM mo le Human Factor Xa ma le Rabbit Factor Xa, faasologa [1].Apixaban na faʻaumiina taimi faʻapipiʻi o le plasma masani o le tagata ma faʻatonuga (EC2x) o le 3.6, 0.37, 7.4 ma le 0.4 μM, lea e manaʻomia taʻitasi e faʻaluaina le taimi o le prothrombin (PT), suiga o le taimi o le prothrombin (mPT), faʻagaoioia vaega o le thromboplastin taimi ( APTT) ma HepTest.E le gata i lea, na faʻaalia e Apixaban le maualuga maualuga o le plasma o le tagata ma le lapiti, ae faʻaitiitia le malosi i le plasma ma le dog plasma i le PT ma le APTT assays [3].

In vivo: Apixaban na faʻaalia le pharmacokinetics sili ona lelei ma le kilia maualalo (Cl: 0.02 L kg-1h-1), ma le maualalo o le tufatufaina (Vdss: 0.2 L / kg) i le taifau.E le gata i lea, na faʻaalia foi e Apixaban se afa-ola lelei ma le T1 / 2 o 5.8 itula ma le lelei o le bioavailability oral (F: 58%) [1].I le arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) ma faʻataʻitaʻiga lapiti carotid arterial thrombosis (ECAT), na maua ai e Apixaban aʻafiaga antithrombotic ma le EC50 o le 270 nM, 110 nM ma le 70 nM i se fua faʻalagolago [3]. ].O le Apixaban na matua faʻalavelaveina le gaioiga Xa faʻatasi ma le IC50 o le 0.22 μM i le lapiti ex vivo [4].I le chimpanzee, na faʻaalia foi e Apixaban le laʻititi o le tufatufaina atu (Vdss: 0.17 L kg-1), maualalo le kilia o le tino (Cl: 0.018 L kg-1h-1), ma le lelei o le bioavailability oral (F: 59%) [5].

Fa'asinomaga:
Pinto DJP, Orwat MJ, Koch S, ma isi.Su'esu'ega o le 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl) -4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4- c] pyridine-3-carboxamide (Apixaban, BMS-562247), o se mea e sili ona malosi, filifilia, aoga, ma le faʻaogaina o le faʻaogaina o le toto o le toto Xa [J].Journal of chemistry medicinal, 2007, 50(22): 5339-5356.
Sidhu P S. Fa'atonu Tu'usa'o Xa Inhibitors e fai ma Anticoagulants[J].
Wong PC, Crain EJ, Xin B, ma isi.Apixaban, o se mea tuugutu, tuusao ma sili ona filifilia mea Xa inhibitor: in vitro, antithrombotic ma antihemostaticstudies [J].Journal of Thrombosis and Haemostasis, 2008, 6(5): 820-829.
Zhang D, He K, Raghavan N, ma isi.Metabolism, pharmacokinetics ma pharmacodynamics o le mea Xa inhibitor apixaban i lapiti [J].Journal of thrombosis and thrombolysis, 2010, 29 (1): 70-80.
He K, Luettgen JM, Zhang D, et al.Preclinical pharmacokinetics ma pharmacodynamics o le apixaban, o se mea malosi ma filifili Xa inhibitor [J].Tusitala Europa o fualaau faasaina metabolism ma pharmacokinetics, 2011, 36(3): 129-139.

O le Apixaban o se inhibitor sili ona filifilia ma toe faʻafoʻi o Factor Xa faʻatasi ai ma Ki tau o le 0.08 nM ma le 0.17 nM i le tagata ma le lapiti, i le faasologa [1].

Factor X, e lauiloa foi i le eponym Stuart-Prower factor, o se enzyme o le coagulation cascade.O le Factor X e fa'agaoioia, e ala ile hydrolysis, ile fa'ale Xa e lua itu IX.Factor Xa o le fa'agaoioia fomu o le coagulation factorthrombokinase. Inhibiting Factor Xa e mafai ona ofoina atu se isi auala mo anticoagulation.Direct Xa iniseti o anticoagulants lauiloa [2].

In vitro: Apixabanhas na faʻaalia se maualuga maualuga o le malosi, filifilia, ma le aoga ile Factor Xa ma le Ki o le 0.08 nM ma le 0.17 nM mo le Human Factor Xa ma le Rabbit Factor Xa, faasologa [1].Apixaban na faʻaumiina taimi faʻapipiʻi o le plasma masani o le tagata ma faʻatonuga (EC2x) o le 3.6, 0.37, 7.4 ma le 0.4 μM, lea e manaʻomia taʻitasi e faʻaluaina le taimi o le prothrombin (PT), suiga o le taimi o le prothrombin (mPT), faʻagaoioia vaega o le thromboplastin taimi ( APTT) ma HepTest.E le gata i lea, na faʻaalia e Apixaban le maualuga maualuga o le plasma o le tagata ma le lapiti, ae faʻaitiitia le malosi i le plasma ma le dog plasma i le PT ma le APTT assays [3].

In vivo: Apixaban na faʻaalia le pharmacokinetics sili ona lelei ma le kilia maualalo (Cl: 0.02 L kg-1h-1), ma le maualalo o le tufatufaina (Vdss: 0.2 L / kg) i le taifau.E le gata i lea, na faʻaalia foi e Apixaban se afa-ola lelei ma le T1 / 2 o 5.8 itula ma le lelei o le bioavailability oral (F: 58%) [1].I le arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) ma faʻataʻitaʻiga lapiti carotid arterial thrombosis (ECAT), na maua ai e Apixaban aʻafiaga antithrombotic ma le EC50 o le 270 nM, 110 nM ma le 70 nM i se fua faʻalagolago [3]. ].O le Apixaban na matua faʻalavelaveina le gaioiga Xa faʻatasi ma le IC50 o le 0.22 μM i le lapiti ex vivo [4].I le chimpanzee, na faʻaalia foi e Apixaban le laʻititi o le tufatufaina atu (Vdss: 0.17 L kg-1), maualalo le kilia o le tino (Cl: 0.018 L kg-1h-1), ma le lelei o le bioavailability oral (F: 59%) [5].

Fa'asinomaga:
Pinto DJP, Orwat MJ, Koch S, ma isi.Su'esu'ega o le 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl) -4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4- c] pyridine-3-carboxamide (Apixaban, BMS-562247), o se mea e sili ona malosi, filifilia, aoga, ma le faʻaogaina o le faʻaogaina o le toto o le toto Xa [J].Journal of chemistry medicinal, 2007, 50(22): 5339-5356.
Sidhu P S. Fa'atonu Tu'usa'o Xa Inhibitors e fai ma Anticoagulants[J].
Wong PC, Crain EJ, Xin B, ma isi.Apixaban, o se mea tuugutu, tuusao ma sili ona filifilia mea Xa inhibitor: in vitro, antithrombotic ma antihemostaticstudies [J].Journal of Thrombosis and Haemostasis, 2008, 6(5): 820-829.
Zhang D, He K, Raghavan N, ma isi.Metabolism, pharmacokinetics ma pharmacodynamics o le mea Xa inhibitor apixaban i lapiti [J].Journal of thrombosis and thrombolysis, 2010, 29 (1): 70-80.
He K, Luettgen JM, Zhang D, et al.Preclinical pharmacokinetics ma pharmacodynamics o le apixaban, o se mea malosi ma filifili Xa inhibitor [J].Tusitala Europa o fualaau faasaina metabolism ma pharmacokinetics, 2011, 36(3): 129-139.

Fa'asologa o vaila'au

Apixaban

PULEGA UIGA

Quality management1

Fautuaga18Poloketi Iloiloga Tulaga Tulaga Lelei ua fa'amaonia4, ma6o lo'o i lalo le faamaoniga.

Quality management2

A'oa'oga fa'ava-o-malo pulega lelei faiga ua faataatia faavae mautu mo le faatauina atu.

Quality management3

O le va'aiga lelei e fa'atautaia i le taamilosaga atoa o le olaga o le oloa ina ia mautinoa le lelei ma le togafitiga.

Quality management4

E lagolagoina e le vaega o Mataupu Tau Fa'apolofesa tulaga mana'omia ile taimi ole talosaga ma le resitalaina.

PULEGA O GALUEGA

cpf5
cpf6

Korea Countec Laina Fa'a'u'u Fagu

cpf7
cpf8

Taiuani CVC Faunoa Laina afifiina

cpf9
cpf10

Italia CAM Board Packaging Line

cpf11

Siamani Fette Compacting Machine

cpf12

Iapani Viswill Tablet Su'esu'e

cpf14-1

Potu Pulea DCS

PAAGA

Felagolagomai faavaomalo
International cooperation
Felagolagomai i totonu o aiga
Domestic cooperation

  • Muamua:
  • Sosoo ai:

  • Tusi lau savali iinei ma lafo mai ia i matou

    Vaega o oloa